PAINWEEK–END–EX60[87]-01

ROSEMONT, IL

Saturday 4/2/22 | 8:00a-5:30p

This is a 1-day meeting and will provide 6 CE/CME credits.

Register Now!

Pain Management for the Main Street Practitioner

Pain is the primary reason Americans seek healthcare. An aging population and radical expansion in health insurance coverage will converge to keep pain at the forefront of patient presentations. And the rapidly evolving regulatory environment in medication risk management has new and complex implications for patients and practitioners alike.

VENUE

chicago main

The Westin O'Hare
6100 North River Rd.
Rosemont, IL 60018

View hotel website >>

chicago-1
chicago-2
chicago-3

FACULTY

(Subject to change)

Charles E. Argoff
MD

kominek-400x400

Courtney M. Kominek
PharmD, BCPS, CPE

David Cosio
PhD, ABPP

knevevic-400x400

Nebojsa Nick Knezevic
MD, PhD

MODERATOR

kominek-400x400

Courtney M. Kominek
PharmD, BCPS, CPE

Register Now!

COURSE AGENDA

(Faculty and courses subject to change)

8:00a-9:00a — Registration, Breakfast, Coffee, and Exhibits


9:00a-10:00a — The Dog Ate My Homework: A Guide to Avoiding Relapse and Maintaining Adherence

Faculty: David Cosio, PhD, ABPP

According to the World Health Organization (WHO), approximately 125,000 people in the US with treatable diseases die each year because they do not take their medication as prescribed. The WHO also reports that 10% to 25% of hospital and nursing home admissions result from patient noncompliance. Adherence rates for behavioral change related to obesity, substance abuse, smoking cessation, and chronic pain have shown similar relapse rates following completion of treatment. Providers can formulate specific procedures for improving patient participation, such as anticipating nonadherence, considering the prescribed self-care curative measures from the patient's perspective, improving the patient-provider relationship, customizing treatment, enlisting family support, and making use of other healthcare providers. This presentation will define compliance, adherence, and relapse, and will offer providers evidence-based strategies, such as building the therapeutic relationship, motivational interviewing, and health coaching interventions, to help maintain long-term gains in their pain management care.

UAN: 0530-0000-22-021-L08-P
Rx hours: 0.00


10:00a-10:15a — Break/Exhibits


10:15a-11:15a — Clinical Update: Utilizing Topical Analgesics for Diabetic Peripheral Neuropathy

Faculty: Charles E. Argoff, MD

Painful diabetic neuropathy is a challenging condition to treat. This course will review the prevalence and impact of painful diabetic neuropathy as well as explore how available topical therapies for this condition can be incorporated into one’s practice. Systemic therapies will also be discussed to provide context for the discussion of topical therapies and because topical therapies are often used in conjunction with systemic treatments.

UAN: 0530-0000-22-008-L01-P
Rx hours: 0.50

Supported by an educational grant from Averitas Pharma, Inc.


11:15a-12:15p — Regenerative Therapy for Chronic Pain: Fact or Fiction?

Faculty: Nebojsa Nick Knezevic, MD, PhD

Regenerative medicine is a subspecialty that seeks to recruit and enhance the body’s own inherent healing armamentarium in the treatment of patient pathology. This therapy’s intention is to assist in the repair, and to potentially replace or restore damaged tissue, through the use of autologous or allogenic biologics. This field is rising like a phoenix from the ashes of underperforming conventional therapy midst the hopes and expectations of patients and medical personnel alike. But, because this is a relatively new area of medicine that has yet to substantiate its outcomes, care must be taken in its public presentation and promises as well as in its use. Regenerative therapy should be provided to patients following 1) diagnostic evidence of a need for biologic therapy, 2) a thorough discussion of the patient’s needs and expectations, 3) educating the patient on the use and administration of biologics, and 4) in the full light of the patient’s medical history. Regenerative therapy may be provided independently or in conjunction with other modalities of treatment including a structured exercise program, physical therapy, behavioral therapy, and appropriate conventional medical therapy as necessary.

UAN: 0530-0000-22-017-L08-P
Rx hours: 0.0


12:15p-12:30p — Break/Exhibits


12:30p-1:30p — Beyond OTC Laxatives: Taking a Targeted Approach to Managing Opioid-Induced Constipation*

Faculty: Neel Mehta, MD

Lunch will be served.

Sponsored by Salix Pharmaceuticals.

*Not certified for credit


1:30p-2:30p — All in the Family: Their Role and Impact on Pain Management

Faculty: David Cosio, PhD, ABPP

About 43% of households have at least 1 person with chronic pain, and that pain affects all members of the family, plus caregivers and/or significant others. It can demoralize and depress both patient and family, especially when there is no effective pain control and no hope for relief. Family can have a role in maintaining the pain, and should be included in pain assessment and treatment of pain. Family members must not only recognize and overcome obstacles that may occur when communicating with chronic pain patients, but also must deal with their own pain and stress. Addressing emotions with support groups, family therapy, or individual therapy can strengthen the family and the individual, as well as reduce the suffering of all involved. It is important for frontline practitioners to consider not only the person who is suffering in front of them, but the people behind the patient.

UAN: 0530-0000-22-005-L08-P
Rx hours: 0.00


2:30p-2:40p — Break/Exhibits


2:40p-3:30p — Building Confidence and Establishing Best Practices for Administering QUTENZA® (capsaicin) 8% topical system*

Faculty: Stephanie Simon, APRN

This hands-on workshop will allow you to practice the application steps and technique surrounding a QUTENZA treatment. Demonstration topical systems and patient actors will be available for you to gain hands-on experience and develop best practices.

Sponsored by Averitas Pharma, Inc.

Refreshments will be served.

*Not certified for credit


3:30p-4:30p — See, Be, Deceived…or Relieved? Evaluating CBD for Pain Management

Faculty: Courtney M. Kominek, PharmD, BCPS, CPE

How many times a week (or a day) does a patient ask you about cannabidiol (CBD)? This session will take a deeper dive into CBD and learn how it compares to cannabis and what evidence there is (if any) to support its use in pain management. What considerations should you make when co-prescribing for a patient using CBD? In this session, we’ll compare and contrast the mechanism of action of THC and CBD and how each affects the nervous system and examine the published evidence on the use of CBD in pain management, including studied dosage forms and pain indications. Finally, we’ll review the potential implications of prescribing or recommending CBD for pain management.

UAN: 0530-0000-22-018-L08-P
Rx hours: 0.30


4:30p-5:30p — Interventional Options for Refractory Migraine and Cervicogenic Headaches

Faculty: Nebojsa Nick Knezevic, MD, PhD

Migraines are a highly prevalent condition, affecting 12% of the population. Cervicogenic headaches are chronic and recurrent and present as unilateral pain starting in the neck, accompanied by reduced range of motion. Its prevalence is 1% to 4%. These headaches manifest as referred pain arising from irritation caused by cervical structures innervated by C1-3 spinal nerves. Physical therapy is considered the first line of treatment. Spinal manipulative therapy and therapeutic exercise regimens are effective in treating headache. We will discuss interventional pain modalities, such as peripheral nerve stimulation, third occipital nerve block, lesser occipital nerve block, greater occipital nerve block, sphenopalatine block, radiofrequency ablation, and cervical epidural steroid injections. Various approaches to cervicogenic headaches will be reviewed, including lateral atlantoaxial joint intra-articular injections and C2 nerve root coblation.

UAN: 0530-0000-22-012-L01-P
Rx hours: 0.20


REGISTRATION INFORMATION

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Fee: $129

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend sponsored meal programs and the scientific sessions.

SPONSORED PROGRAMS

To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon time slots.

Register Now!

Accreditation

PAINWeekEnd Rosemont 2022
This activity is provided by Global Education Group.

Target Audience

The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.

Statement of Need/Program Overview

Whether you're in a hospital or office-based practice, chronic pain patients are everywhere—and YOU are absorbing the burden of their care.

A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeek Premiere Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.

The PAINWeekEnd agenda is purposely constructed for the busy clinician, delivering 2 full days of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.

Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 6.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.

Learning Objectives

  • Describe the potential negative impact that bias, stigma, and social determinants of health can have in the assessment and treatment of pain

  • Summarize current stakeholder perspectives and oversight trends for opioid prescribing

  • Summarize how different types of opioid risk have varying levels of clinical impact

  • Identify key steps in meaningful risk evaluation of new patients and risk monitoring of established patients

  • Describe the importance of understanding the negotiation of pain and suffering

  • Describe how payers now measure and address patient risk

  • Cite potential drug interactions with cannabis

  • Summarize the general tension between the federal and state law regarding the status of cannabis

Faculty

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Department of Neurology
Albany, NY

Jennifer Bolen, JD
Founder
The Legal Side of Pain
Knoxville, TN

Theresa Mallick-Searle, PMGT-BC, MS
Adult Nurse Practitioner
Stanford Health Care
Division Pain Medicine
San Carlos, CA

Kevin L. Zacharoff, MD, FACIP, FACPE, FAAP
Faculty and Clinical Instructor
Course Director Pain and Addiction
SUNY Stony Brook School of Medicine
Stony Brook, NY
Ethics Committee Chair
St Catherine of Siena Medical Center
Smithtown, NY

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner Continuing Education

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 6.0 contact hour(s) (which includes 1.0 hour(s) of pharmacology).

Nursing Credit Designation

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 6.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.

Pharmacy Credit Designation

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 6.0 contact hours (0.60 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity. UANs are in the agenda.

Instructions to Receive Credit

Please look for an email from outcomes@globaleducationgroup.com that will be sent to you following this Premiere Webinar. The email will have your personalized link to complete the online conference evaluation form needed to receive your CE/CME certificate. Upon completion of this form, you will be able to download, print, and save your certificate immediately! Please make sure to check your junk mail folder, as this email may be tagged as spam.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The planners and managers reported the following financial relationships or relationships to products or devices they have with ineligible company related to the content of this CME activity:

Rhys Williams, MSN, FNP-C, RN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Andrea Funk—Nothing to disclose
Liddy Knight—Nothing to disclose
Ashley Cann—Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.